Nicole Mentens

4.1k total citations
33 papers, 2.4k citations indexed

About

Nicole Mentens is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Nicole Mentens has authored 33 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 15 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Nicole Mentens's work include Chronic Myeloid Leukemia Treatments (17 papers), Acute Lymphoblastic Leukemia research (14 papers) and Acute Myeloid Leukemia Research (8 papers). Nicole Mentens is often cited by papers focused on Chronic Myeloid Leukemia Treatments (17 papers), Acute Lymphoblastic Leukemia research (14 papers) and Acute Myeloid Leukemia Research (8 papers). Nicole Mentens collaborates with scholars based in Belgium, United States and Netherlands. Nicole Mentens's co-authors include Jan Cools, Peter Marynen, Iwona Włodarska, Anne Hagemeijer, Raf Sciot, Maria Dêbiec‐Rychter, A. van Oosterom, Peter Vandenberghe, Hans Prenen and Cedric Folens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Nicole Mentens

33 papers receiving 2.3k citations

Peers

Countries citing papers authored by Nicole Mentens

Since Specialization

Citations

This map shows the geographic impact of Nicole Mentens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Mentens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Mentens more than expected).

Fields of papers citing papers by Nicole Mentens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Mentens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Mentens. The network helps show where Nicole Mentens may publish in the future.

Co-authorship network of co-authors of Nicole Mentens

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Mentens. A scholar is included among the top collaborators of Nicole Mentens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Mentens. Nicole Mentens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia 2025 ·Leukemia ·(unknown), (unknown), Sofie Demeyer, Nicole Mentens, (unknown), Kris Jacobs, Olga Gielen, (unknown), Charles E. de Bock, Guillaume P. Andrieu, (unknown), Jan Cools, (unknown)	1
2	Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma 2022 ·Blood ·Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, (unknown), (unknown), Cristina Prieto, (unknown), Nicole Mentens, Kris Jacobs, Olga Gielen, David Nittner, Seishi Ogawa, Keisuke Kataoka, Carlos Graux, Thomas Tousseyn, Jan Cools, Daan Dierickx	12
3	TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia 2022 ·Haematologica ·(unknown), Sofie Demeyer, Nicole Mentens, Olga Gielen, (unknown), Jan Cools	9
4	Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified 2021 ·Nature Communications ·Koen Debackere, Lukas Marcelis, Sofie Demeyer, Marlies Vanden Bempt, Nicole Mentens, Olga Gielen, Kris Jacobs, Michaël Broux, Gregor Verhoef, Lucienne Michaux, Carlos Graux, Iwona Włodarska, Philippe Gaulard, Laurence de Leval, Thomas Tousseyn, Jan Cools, Daan Dierickx	18
5	The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia 2020 ·Clinical Cancer Research ·Delphine Verbeke, Sofie Demeyer, Cristina Prieto, Charles E. de Bock, Jolien De Bie, Olga Gielen, Kris Jacobs, Nicole Mentens, Bronte Manouk Verhoeven, Anne Uyttebroeck, Nancy Boeckx, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools	21
6	Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia 2019 ·Blood ·Michaël Broux, Cristina Prieto, Sofie Demeyer, Marlies Vanden Bempt, Llucia Albertí Servera, Inge Lodewijckx, Roel Vandepoel, Nicole Mentens, Olga Gielen, Kris Jacobs, Ellen Geerdens, Carmen Vicente, Charles E. de Bock, Jan Cools	33
7	Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia 2018 ·Cancer Cell ·Marlies Vanden Bempt, Sofie Demeyer, Michaël Broux, Jolien De Bie, Simon Bornschein, Nicole Mentens, Roel Vandepoel, Ellen Geerdens, Enrico Radaelli, Beat Bornhäuser, Andreas E. Kulozik, Jules P.P. Meijerink, Jean‐Pierre Bourquin, Charles E. de Bock, Jan Cools	42
8	Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene 2017 ·Haematologica ·(unknown), Marlies Vanden Bempt, José Luis Ferreiro, Nicole Mentens, Kris Jacobs, (unknown), (unknown), Ellen Geerdens, Anne Uyttebroeck, (unknown), Lucienne Michaux, Timothy Devos, Peter Vandenberghe, Thomas Tousseyn, Jan Cools, Iwona Włodarska	26
9	Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia 2013 ·PLoS Genetics ·Zeynep Kalender Atak, Valentina Gianfelici, Gert Hulselmans, Kim De Keersmaecker, (unknown), Ellen Geerdens, Nicole Mentens, Sabina Chiaretti, Kaat Durinck, Anne Uyttebroeck, Peter Vandenberghe, Iwona Włodarska, Jacqueline Cloos, (unknown), Frank Speleman, Jan Cools, Stein Aerts	99
10	NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins 2013 ·Haematologica ·Kim De Keersmaecker, Michaël Porcu, Luk Cox, Tiziana Girardi, Roel Vandepoel, (unknown), (unknown), Nicole Mentens, Keiryn L. Bennett, Oliver Hantschel	35
11	MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context 2010 ·Haematologica ·(unknown), Nicole Mentens, Thomas Tousseyn, Iwona Włodarska, Jan Cools	10
12	Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia 2010 ·Nature Genetics ·Maria Kleppe, Idoya Lahortiga, (unknown), Kim De Keersmaecker, Nicole Mentens, Carlos Graux, Katrien Van Roosbroeck, Adolfo A. Ferrando, Anton W. Langerak, Jules P.P. Meijerink, François Sigaux, Torsten Haferlach, Iwona Włodarska, Peter Vandenberghe, Jean Soulier, Jan Cools	141
13	In vitro validation of -secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia 2008 ·Haematologica ·Kim De Keersmaecker, Idoya Lahortiga, Nicole Mentens, Cedric Folens, Leander Van Neste, Sofie Bekaert, Peter Vandenberghe, María D. Odero, Peter Marynen, Jan Cools	58
14	The ability of sorafenib to inhibit oncogenic PDGFR and FLT3 mutants and overcome resistance to other small molecule inhibitors 2007 ·Haematologica ·Els Lierman, Idoya Lahortiga, Helen Van Miegroet, Nicole Mentens, Peter Marynen, Jan Cools	68
15	Intestinal Neurofibromatosis Is a Subtype of Familial GIST and Results From a Dominant Activating Mutation in PDGFRA 2006 ·Gastroenterology ·Thomas De Raedt, Jan Cools, Maria Dêbiec‐Rychter, Hilde Brems, Nicole Mentens, Raf Sciot, Jacqués Himpens, Ivo De Wever, Patrick Schöffski, Peter Marynen, Eric Legius	55
16	563 POSTER In vitro activity of the multi-targeted kinase inhibitor sorafenib (BAY43-9006) against gastrointestinal stromal tumor (GIST) mutants refractory to imatinib mesylate 2006 ·European Journal of Cancer Supplements ·Hans Prenen, Barbara Dewaele, Jan Cools, Nicole Mentens, Cristiana Stefan, Raf Sciot, Patrick Schöffski, Peter Marynen, A.T. van Oosterom, Maria Dêbiec‐Rychter	2
17	Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants 2005 ·Gastroenterology ·Maria Dêbiec‐Rychter, Jan Cools, Herlinde Dumez, Raf Sciot, Michel Stul, Nicole Mentens, Hilde Vranckx, Bartosz Wasąg, Hans Prenen, Johannes Roesel, Anne Hagemeijer, A. van Oosterom, Peter Marynen	396
18	An Examination of the Differential Sensitivity to Ketolide Antibiotics in ermB Strains of Streptococcus pyogenes and Streptococcus pneumoniae 2004 ·Current Microbiology ·W. Scott Champney, Nicole Mentens, (unknown)	10
19	Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor 2002 ·Genes Chromosomes and Cancer ·Jan Cools, Iwona Włodarska, (unknown), Nicole Mentens, Florence Pédeutour, Brigitte Maes, Christiane De Wolf‐Peeters, Patrick Pauwels, Anne Hagemeijer, Peter Marynen	210
20	A new family of small, palmitoylated, membrane‐associated proteins, characterized by the presence of a cysteine‐rich hydrophobic motif 2001 ·FEBS Letters ·Jan Cools, Nicole Mentens, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact